These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 28703764)

  • 1. Erythropoietin and Its Angiogenic Activity.
    Kimáková P; Solár P; Solárová Z; Komel R; Debeljak N
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28703764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin in tumor angiogenesis.
    Annese T; Tamma R; Ruggieri S; Ribatti D
    Exp Cell Res; 2019 Jan; 374(2):266-273. PubMed ID: 30576679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of erythropoietin in the angiogenic activity of bone marrow endothelial cells of MGUS and multiple myeloma patients.
    Lamanuzzi A; Saltarella I; Ferrucci A; Ria R; Ruggieri S; Racanelli V; Rao L; Annese T; Nico B; Vacca A; Ribatti D
    Oncotarget; 2016 Mar; 7(12):14510-21. PubMed ID: 26919105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiogenic effects of erythropoietin.
    Ribatti D
    Int Rev Cell Mol Biol; 2012; 299():199-234. PubMed ID: 22959304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin and the heart: physiological effects and the therapeutic perspective.
    Sanchis-Gomar F; Garcia-Gimenez JL; Pareja-Galeano H; Romagnoli M; Perez-Quilis C; Lippi G
    Int J Cardiol; 2014 Feb; 171(2):116-25. PubMed ID: 24377712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of erythropoietin in regulating angiogenesis.
    Kertesz N; Wu J; Chen TH; Sucov HM; Wu H
    Dev Biol; 2004 Dec; 276(1):101-10. PubMed ID: 15531367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of the erythropoietin/erythropoietin receptor system as a novel cardiovascular therapeutic target.
    Satoh K; Fukumoto Y; Nakano M; Kagaya Y; Shimokawa H
    J Cardiovasc Pharmacol; 2011 Dec; 58(6):570-4. PubMed ID: 21934628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin accelerates tumor growth through increase of erythropoietin receptor (EpoR) as well as by the stimulation of angiogenesis in DLD-1 and Ht-29 xenografts.
    Tankiewicz-Kwedlo A; Hermanowicz J; Surażynski A; Rożkiewicz D; Pryczynicz A; Domaniewski T; Pawlak K; Kemona A; Pawlak D
    Mol Cell Biochem; 2016 Oct; 421(1-2):1-18. PubMed ID: 27543111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization.
    Westenbrink BD; Lipsic E; van der Meer P; van der Harst P; Oeseburg H; Du Marchie Sarvaas GJ; Koster J; Voors AA; van Veldhuisen DJ; van Gilst WH; Schoemaker RG
    Eur Heart J; 2007 Aug; 28(16):2018-27. PubMed ID: 17576662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain and cancer: the protective role of erythropoietin.
    Buemi M; Caccamo C; Nostro L; Cavallaro E; Floccari F; Grasso G
    Med Res Rev; 2005 Mar; 25(2):245-59. PubMed ID: 15389732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of the role of erythropoietin in critical leg ischemia.
    Joshi D; Tsui J; Ho TK; Selvakumar S; Abraham DJ; Baker DM
    Angiology; 2010 Aug; 61(6):541-50. PubMed ID: 20462898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietin, erythropoiesis and beyond.
    Chateauvieux S; Grigorakaki C; Morceau F; Dicato M; Diederich M
    Biochem Pharmacol; 2011 Nov; 82(10):1291-303. PubMed ID: 21782802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythropoietin biology in cancer.
    Hardee ME; Arcasoy MO; Blackwell KL; Kirkpatrick JP; Dewhirst MW
    Clin Cancer Res; 2006 Jan; 12(2):332-9. PubMed ID: 16428469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin and cancer: the unintended consequences of anemia correction.
    Debeljak N; Solár P; Sytkowski AJ
    Front Immunol; 2014; 5():563. PubMed ID: 25426117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Many Facets of Erythropoietin Physiologic and Metabolic Response.
    Suresh S; Rajvanshi PK; Noguchi CT
    Front Physiol; 2019; 10():1534. PubMed ID: 32038269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin is involved in the angiogenic potential of bone marrow macrophages in multiple myeloma.
    De Luisi A; Binetti L; Ria R; Ruggieri S; Berardi S; Catacchio I; Racanelli V; Pavone V; Rossini B; Vacca A; Ribatti D
    Angiogenesis; 2013 Oct; 16(4):963-73. PubMed ID: 23881169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epo and non-hematopoietic cells: what do we know?
    Ogunshola OO; Bogdanova AY
    Methods Mol Biol; 2013; 982():13-41. PubMed ID: 23456860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted near-infrared imaging of the erythropoietin receptor in human lung cancer xenografts.
    Doleschel D; Mundigl O; Wessner A; Gremse F; Bachmann J; Rodriguez A; Klingmüller U; Jarsch M; Kiessling F; Lederle W
    J Nucl Med; 2012 Feb; 53(2):304-11. PubMed ID: 22228796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin in cancer: an update.
    Tóvári J; Pirker R; Tímár J; Ostoros G; Kovács G; Döme B
    Curr Mol Med; 2008 Sep; 8(6):481-91. PubMed ID: 18781955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous erythropoietin and erythropoietin receptors in colorectal cancer; can we answer the questions?
    Čubranić A; Dobrila-Dintinjana R; Redžović A; Dintinjana M; Petranović D; Golčić M
    Med Hypotheses; 2016 Nov; 96():16-19. PubMed ID: 27959268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.